Reduced radiation exposure
The growing demand for PETCT in oncology posed a challenge for Central Manchester University Hospitals NHS Foundation Trust, with a projected 14 per cent annual increase in scanning numbers. Its use of F18 Fludeoxyglucose (18F-FDG) in oncology produced reliable results, but there was a clear need to increase efficiency to accommodate this increasing demand. Additionally, departmental physicists were looking for ways to reduce dose exposure while maintaining the same high quality results. Both staff and patients, some of them relatively young, were being exposed to high levels of ionising radiation during PETCT scans.
The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.